Efficacy of rosiglitazone and pioglitazone compared to other anti-diabetic agents: systematic review and budget impact analysis
By: Canadian Coordinating Office for Health Technology Assessment
Publisher: Canadian Coordinating Office for Health Technology Assessment
Place of publication: Ottawa
Number of pages: 76
Subjects: Diabetes mellitus -- drug therapy; hypoglycemic agents -- therapeutic use
Notes: "October 2002" Technology Report

2